Alexandra N.Fries (Alex)

Associate

Los Angeles + 1.213.243.2360

Alex Fries represents businesses in high-stakes complex litigation. As a commercial litigator, her practice involves product liability, contracts, class actions, multidistrict litigation, fraud, health care, securities and financial products, and business torts. She has argued motions in state and federal courts and has defended clients in multiple trials. She is experienced in working on and managing litigation teams on all aspects of the case and is skilled in all facets of fact and expert discovery.

Recently, Alex defended a major retailer in hundreds of cases brought by states and municipalities alleging a public nuisance and prevailed in a jury trial for pharmaceutical company Celgene.

Alex maintains an active pro bono practice. She was lead counsel on two trials in Los Angeles Superior Court in which she obtained restraining orders for victims of domestic violence. Alex also provides pro bono legal assistance through Jones Day's Border Project.

Experience

  • Celgene wins complete defense verdict in case filed by health insurer, Humana Inc., relating to off-label use of cancer medicationsOn March 2, 2023, Jones Day prevailed in a five-week jury trial on behalf of Celgene Corporation in a lawsuit brought by health insurance company Humana, Inc.
  • MF Global Litigation Trust pursues claims against Jon Corzine and other former officersAs part of MF Global Holdings' confirmed plan of reorganization, Jones Day is representing the Litigation Trustee as plaintiff pursuing claims on behalf of creditors brought against Jon Corzine and other former officers for damages resulting from MF Global's demise.
  • Sony settles antitrust class action involving employee compensationJones Day defended Sony Pictures Entertainment Inc. and settled an antitrust class action brought on behalf of a nationwide class of current and former employees of several film animation companies alleging the defendants entered into a conspiracy to suppress employee compensation through non-solicitation agreements and sharing compensation information.
  • Current and former outside directors of American Apparel defend allegations of breach of fiduciary dutyJones Day represented the current and former outside directors of American Apparel in a shareholder plaintiffs' claim alleging that the board of directors, in suspending and ultimately terminating the company's founder and chief executive officer, breached their fiduciary duties by failing to act sooner and by failing to adopt certain corporate governance safeguards to protect against a potential takeover and the triggering of a default on the company's line of credit.
  • Emulex is granted motion to dismiss in breach of fiduciary claimJones Day represented former and current directors of Emulex Corporation in breach of fiduciary duty claim.
  • Avanir Pharmaceuticals defeats motion for preliminary injunction seeking to enjoin shareholder voteJones Day represented Avanir Pharmaceuticals, Inc. in a motion for preliminary injunction that sought to enjoin a shareholder vote on Avanir's proposed equity compensation plan.
  • United PanAm Financial defends minority shareholders' "bump-up" actionJones Day client United PanAm Financial Corp. ("UPFC") obtained dismissal of a minority shareholders' "bump-up" action seeking to challenge UPFC's public merger, based on the exclusivity of an appraisal remedy under California law.